JAM
VNDA icon

JW Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

JW Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-71,377
Closed -$805K – 51
2015
Q3 		$805K Sell
71,377
-27,398
-28% -$335K 0.29% 34
2015
Q2 		$1.25M Buy
98,775
+28,695
+41% +$309K 0.38% 33
2015
Q1 		$652K Buy
70,080
+2,334
+3% +$26.4K 0.28% 34
2014
Q4 		$971K Buy
+67,746
New +$802K 0.73% 27

Other funds holding VNDA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JW Asset Management's VNDA Position: Q4 2015 in Review

JW Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2015, closing a stake of 71,377 shares — an estimated $805K sold.

JW Asset Management first reported a position in VNDA in Q4 2014 and held it in 4 quarters. The position peaked at $1.25M in Q2 2015. 117 funds tracked by Wall St. Rank hold VNDA as of Q4 2015.

  • JW Asset Management reported no remaining Vanda Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • JW Asset Management sold 71,377 Vanda Pharmaceuticals shares in Q4 2015, an estimated $805K.
  • JW Asset Management first reported a position in Vanda Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • JW Asset Management's Vanda Pharmaceuticals position peaked at $1.25M in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2015.

Based on JW Asset Management's 13F filing for Q4 2015, filed 9 Feb 2016.